---
schema_version: "secwatch.filing_event.v1"
accession: "0001645113-23-000032"
form_type: "8-K"
ticker: "NVCR"
cik: "0001645113"
company_name: "NovoCure Ltd"
filed_at: "2023-03-29T23:59:59+00:00"
generated_at: "2026-06-17T10:33:07.705137+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Novocure elects Kristin Stafford to board of directors

## Summary
- Kristin Stafford elected to Novocure board effective March 28, 2023.
- She is SVP, Chief Accounting Officer at Royalty Pharma plc.
- She receives option grant of $667,000 fair value, vesting over three years.
- She joins Compensation Committee.

## SEC filing metadata
- accession: 0001645113-23-000032
- form_type: 8-K
- ticker: NVCR
- cik: 0001645113
- company_name: NovoCure Ltd
- filed_at: 2023-03-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1645113/000164511323000032/0001645113-23-000032-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1645113/000164511323000032/nvcr-20230328.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001645113-23-000032
- JSON: https://secwatch.observer/filing/0001645113-23-000032.json
- Plain text: https://secwatch.observer/filing/0001645113-23-000032.txt

## Key facts
- Executive change
  Kristin Stafford was elected as director at NovoCure Ltd.
  - Action: elected
  - Role: director
  source text: On March 28, 2023 , the Board of Directors (the “Board”) of NovoCure Limited (the "Company") elected Kristin Stafford as a director of the Company, effective immediately, increasing the size of the Board to ten members.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1645113/000164511323000032/0001645113-23-000032-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.